Jessica Hagen

Precision Neuroscience announced it successfully implanted its nonpenetrating BCI in able-bodied neurosurgical patients and is advancing toward a permanent implant.

The pharma giant alleges Eli Lilly is using outdated scientific research in their GLP-1 ads causing misleading impressions in consumers that Lilly's medicines are superior.

David Niewolny, head of healthcare and medical at NVIDIA, discusses how agentic AI and robotics could transform patient care, clinical workflows and drug development.

The company said the Series D funding brings its valuation to three times what it was when it raised its $52 million Series C funding last year.

The lawsuit claims ChatGPT-4o discouraged the plaintiff from seeking medical treatment and manipulated him through conversations about his health and faith, resulting in a nearly fatal pulmonary embolism.

The AI voice tool has been deployed throughout the Central Texas-based multispecialty medical group's 40 locations.

David Niewolny, head of healthcare and medical at NVIDIA, describes how AI could reshape healthcare in the coming years as patients and clinicians become more comfortable with autonomous technologies.

The pharma giant is asking a federal court to temporarily prohibit Eli Lilly from airing comparative GLP-1 advertisements while the lawsuit proceeds.

Frederik Mueller, Third Way Health CEO and cofounder, and Jamie Reddick, chief operating officer of Graybill Medical Group, discuss blending people and technology to ease front-office workflows.

Lori Reece, healthcare solutions director at uPerform, describes how software training for clinical applications should evolve as technology progresses to improve workforce adoption and efficiency.